JYHB2000467 | 二甲双胍恩格列净片(Ⅳ) | empagliflozin;metformin hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2020-04-22 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2020-05-14 | view |
JYHZ2300308 | 二甲双胍恩格列净片(Ⅳ) | empagliflozin;metformin hydrochloride | Tablet | Chemical Drugs | License Renew | 2023-07-15 | | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | | | view |
JYHB2001001 | 二甲双胍恩格列净片(Ⅳ) | empagliflozin;metformin hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2020-07-03 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2020-08-21 | view |
JYHB2000799 | 二甲双胍恩格列净片(Ⅳ) | empagliflozin;metformin hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2020-06-19 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2020-07-07 | view |
CYHS2404150 | 二甲双胍恩格列净片(Ⅳ) | empagliflozin;metformin hydrochloride | Tablet | Chemical Drugs(4) | Generic Drug | 2024-12-03 | | Ningbo Krka Menovo Pharmaceutical Co Ltd;Ningbo Menovo TianKang Pharmaceutical Co Ltd | | | view |
JYHB2000705 | 二甲双胍恩格列净片(Ⅳ) | empagliflozin;metformin hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2020-06-04 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | Filed | 2020-06-16 | view |
JYHZ2300307 | 二甲双胍恩格列净片(Ⅳ) | empagliflozin;metformin hydrochloride | Tablet | Chemical Drugs | License Renew | 2023-07-15 | | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG | | | view |